Cargando…

Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy

The aim of this study was to evaluate the effectiveness and tolerability of definitive chemo-radiation or radiotherapy alone in patients with esophageal cancer. We retrospectively analyzed the medical records of n = 238 patients with squamous cell carcinoma or adenocarcinoma of the esophagus treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haefner, Matthias F., Lang, Kristin, Krug, David, Koerber, Stefan A., Uhlmann, Lorenz, Kieser, Meinhard, Debus, Juergen, Sterzing, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497395/ https://www.ncbi.nlm.nih.gov/pubmed/25907360 http://dx.doi.org/10.1093/jrr/rrv022

Ejemplares similares

Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity
por: Haefner, Matthias Felix, et al.
Publicado: (2017)

Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer
por: Haefner, M. F., et al.
Publicado: (2016)

Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
por: Koerber, Stefan Alexander, et al.
Publicado: (2014)

Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study
por: Liermann, Jakob, et al.
Publicado: (2020)

Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III - The OVAR-IMRT-02 Study
por: Rochet, Nathalie, et al.
Publicado: (2011)

Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients
por: Sterzing, Florian, et al.
Publicado: (2015)

Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity
por: Ristau, J., et al.
Publicado: (2021)

Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
por: Hauswald, Henrik, et al.
Publicado: (2012)

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
por: Baumann, Brian C., et al.
Publicado: (2020)

Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial
por: Krause, Sonja, et al.
Publicado: (2012)

Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
por: Yuan, Shuanghu Tiger, et al.
Publicado: (2014)

Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer
por: Roeder, Falk, et al.
Publicado: (2014)

Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial
por: Arians, Nathalie, et al.
Publicado: (2020)

Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study
por: König, Laila, et al.
Publicado: (2021)

Helical intensity-modulated Radiotherapy of the Pelvic Lymph Nodes with Integrated Boost to the Prostate Bed - Initial Results of the PLATIN 3 Trial
por: Katayama, Sonja, et al.
Publicado: (2014)

Intensity‐modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study
por: Rief, Harald, et al.
Publicado: (2015)

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020)

Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

3D-Printed masks as a new approach for immobilization in radiotherapy – a study of positioning accuracy
por: Haefner, Matthias Felix, et al.
Publicado: (2018)

Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy
por: Thieke, Christian, et al.
Publicado: (2015)

Prognostic Value of Sarcopenia and Systemic Inflammation Markers in Patients Undergoing Definitive Radiotherapy for Esophageal Cancer
por: Liang, Huanwei, et al.
Publicado: (2021)

PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy
por: Sistonen, Heli J., et al.
Publicado: (2023)

Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate - first results of the PLATIN 1 trial
por: Habl, Gregor, et al.
Publicado: (2015)

A treatment planning study of combined carbon ion-beam plus photon intensity-modulated radiotherapy
por: Schuppert, Christopher, et al.
Publicado: (2020)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

Hypothesis testing in Bayesian network meta-analysis
por: Uhlmann, Lorenz, et al.
Publicado: (2018)

Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients—First Clinical Results From a Single Center
por: König, Laila, et al.
Publicado: (2019)

Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging
por: Xu, Hongyao, et al.
Publicado: (2019)

Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities
por: Chen, Nai-Bin, et al.
Publicado: (2020)

Definitive Radiotherapy for Squamous Cell Carcinoma of The Oral Cavity: a Single-institution Experience
por: Lang, Kristin, et al.
Publicado: (2021)

Elective Node Irradiation With Integrated Boost to the Prostate Using Helical IMRT–Clinical Outcome of the Prospective PLATIN-1 Trial
por: Koerber, Stefan Alexander, et al.
Publicado: (2019)

Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial
por: Habl, G, et al.
Publicado: (2013)

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
por: Guckenberger, Matthias, et al.
Publicado: (2020)

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
por: Bernhardt, Denise, et al.
Publicado: (2018)

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012)

Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer
por: Zhao, Lina, et al.
Publicado: (2017)

Intensity modulated radiotherapy (IMRT) in the treatment of children and Adolescents - a single institution's experience and a review of the literature
por: Sterzing, Florian, et al.
Publicado: (2009)

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2022)

Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy
por: Safdie, Fernando, et al.
Publicado: (2012)

Adaptive propensity score procedure improves matching in prospective observational trials
por: Weber, Dorothea, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hh8q6gepfpqpa3glrf1vgai98a